Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between attention-deficit/hyperactivity disorder (ADHD) and epilepsy. ADHD increases seizure risk, while patients with epilepsy have an increased prevalence of ADHD. The reasons explaining this association are not fully understood. Proposed mechanisms include effects of antiepileptic medications, underlying neurodevelopmental vulnerability, the effects of chronic seizures and subclinical epileptiform activity on cognitive functions and adrenergic dysfunction. There may also be a common genetic defect underlying both disorders in some families. Antiepileptics associated with ADHD-like side effects include phenobarbital, gabapentin, vigabatrin and topiramate. Methylphenidate has been studied in a double-blind setting against placebo for treatment of ADHD comorbid with epilepsy, and has a good risk-benefit ratio. Amphetamine, atomoxetine, clonidine and guanfacine only have case series to support their use and bupropion should be avoided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Committee on Quality Improvement, S. O. A.-D. D. (2000) · Pediatrics · doi:10.1542/peds.105.5.1158 · Cited by 1,076
Bush, G., Valera, E. M., & Seidman, L. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.034 · Cited by 714
Structural Brain Imaging of Attention-Deficit/Hyperactivity Disorder
Seidman, L. J., Valera, E. M., & Makris, N. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.019 · Cited by 676
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599
Rubia, K., Smith, A. B., Brammer, M. J., Toone, B., & Taylor, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1067 · Cited by 537
A population survey of mental health problems in children with epilepsy
Davies, S., Heyman, I., & Goodman, R. (2003) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2003.tb00398.x · Cited by 524
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040472 · Cited by 253
Johnson, M., Östlund, S., Fransson, G., Kadesjö, B., & Gillberg, C. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708316261 · Cited by 198
Markowitz, J. S., & Patrick, K. S. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140100-00004 · Cited by 123
Cited by
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336
Childhood epilepsy, febrile seizures, and subsequent risk of ADHD
Bertelsen, E. N., Larsen, J. T., Petersen, L., Christensen, J., & Dalsgaard, S. (2016) · Pediatrics · doi:10.1542/peds.2015-4654 · Cited by 82
Brikell, I., Ghirardi, L., D’Onofrio, B. M., Dunn, D. W., Almqvist, C., Dalsgaard, S., Kuja-Halkola, R., & Larsson, H. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.006 · Cited by 85
Metadata
- Authors
- Hamoda, H. M., Guild, D. J., Gumlak, S., Travers, B. H., & Gonzalez-Heydrich, J.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2009-12
- Volume
- 9
- Issue
- 12
- Pages
- 1747-1754
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2002883969
- Cited by
- 51
- References
- 10
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.